PANGEA - A Double-Blind Placebo-Controlled Study with an Open-Label Pilot Phase, Assessing the Efficacy, Tolerability, and Safety of EU C 001 in Patients with Moderate to Severe Traumatic Brain Injury.

  • Cooper, Jamie (Primary Chief Investigator (PCI))
  • Vallance, Shirley (Project Manager)

Project: Research

Project Details

Effective start/end date11/01/1931/12/21


  • Intensive care research
  • Traumatic brain injury
  • Clinical trial